Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
8Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
VivoSim Labs, Inc. (VIVS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
13Total relationships
2Distinct source URLs
5High confidence
0.754Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
VivoSim Labs, Inc. Suppliers
Ticker
Name
Confidence
Evidence
VISCIENT
VISCIENT
92%
For the three and nine months ended December 31, 2025, the Company incurred $ 213,000 and $ 428,000 in R&D consulting expenses from Viscient, respectively.
Reciprocal relationship from MTNB graph: Vice President, Head of Global Legal Affairs of Wockhardt Limited (2008-2012), a global pharmaceutical and biotechnology company, and Senior Counsel and Assis…
VivoSim Labs, Inc. Customers
Ticker
Name
Confidence
Evidence
VISCIENT
VISCIENT
92%
Additionally, for the three and nine months ended December 31, 2025 and 2024, the Company provided approximately $ 5,000 and $ 4,000 of histology services to Viscient, respectively.
Reciprocal relationship from LLY graph: Reciprocal relationship from VIVS graph: Reciprocal relationship from LLY graph: Reciprocal relationship from VIVS graph: Reciprocal relationship from LLY grap…
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 37 PART III 38 Item 10. Directors, Executive Officers and Corporate Governance 38 Item 11. Executive Compensation 38 Item …
AEGIS-CAPITAL-CORP
AEGIS-CAPITAL-CORP
62%
t terms specified in the Intercompany Agreement and as may be further determined by the parties. In addition, the Company and Viscient each agreed to share certain facilities and equipment and, subje…
BICO-GROUP
BICO-GROUP
62%
is time to us, as disclosed in our filings, and we may therefore compete with Viscient for the time commitments of our Executive Chairman from time to time. We may be subject to security breaches or …
CO-LLC
CO-LLC
62%
is time to us, as disclosed in our filings, and we may therefore compete with Viscient for the time commitments of our Executive Chairman from time to time. We may be subject to security breaches or …
DELAWARE-GENERAL-CORPORATION
DELAWARE-GENERAL-CORPORATION
62%
is time to us, as disclosed in our filings, and we may therefore compete with Viscient for the time commitments of our Executive Chairman from time to time. We may be subject to security breaches or …
VISCIENT-BIOSCIENCES-INC
VISCIENT-BIOSCIENCES-INC
62%
is time to us, as disclosed in our filings, and we may therefore compete with Viscient for the time commitments of our Executive Chairman from time to time. We may be subject to security breaches or …
VivoSim Labs, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
VIVS-DEBT
Debt stack $812,000
90%
Market cache reports total debt of $812,000.
VIVS-DEBT-13373
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2014-03-31.
VIVS-DEBT-13372
Warrants outstanding: 8647
90%
xbrl warrant detail from xbrl 2019-09-30.
VivoSim Labs, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for VivoSim Labs, Inc..
VivoSim Labs, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for VivoSim Labs, Inc..
